News
Filter
-
Celebrating the International Day of Women and Girls in Science
-
LifeArc Ventures – strong performance in 2022 & sustained investment in innovation
-
£1 million awarded to develop cutting-edge therapies for motor neuron disease
-
LifeArc portfolio company RQ Bio’s antibody enters clinical trials
-
Alzheimer’s drug lecanemab approved by US regulator
-
Evolving our science to solve complex healthcare challenges
-
2022 wrapped – our highlights from a pivotal year
-
LifeArc partners with EMBARC to improve healthcare for people living with bronchiectasis
-
MND Collaborative Partnership cautiously welcomes new Government funding
-
Repurposed flu medicine could help under 60s recover faster from COVID-19
-
LifeArc announces £10m funding call for new chronic respiratory infection therapies
-
£100m programme to transform care for people living with chronic lung conditions
